首頁 > 市場調查報告書 > 製藥

生物製劑基因治療學和RNAi 分子標靶治療學核酸藥物

適體市場規模、佔有率和成長分析（按類型、應用、技術、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1896094

適體市場規模、佔有率和成長分析（按類型、應用、技術、最終用戶和地區分類）－2026-2033年產業預測

Aptamers Market Size, Share, and Growth Analysis, By Type (DNA Aptamers, RNA Aptamers), By Application (Diagnostics, Therapeutics), By Technology, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球適體市場規模將達到 1.826 億美元，到 2025 年將達到 2.2 億美元，到 2033 年將達到 8 億美元，預測期（2026-2033 年）的複合年成長率為 17.8%。

全球慢性病發病率的上升趨勢，以及標靶治療的日益普及，預計將顯著推動適體需求的成長。對早期診斷解決方案的需求以及對創新診斷技術投資的不斷增加，將進一步促進市場成長。此外，SELEX技術的進步可望為適體市場的企業拓展更多機會。醫療研發投入的快速成長、基因療法的日益廣泛應用以及人們對適體益處的認知不斷提高，預計都將促進市場擴張。然而，半衰期短、替代療法的出現、接受度有限以及嚴格的法規環境等挑戰可能會抑制市場需求。已開發地區，尤其是美國和加拿大，為適體供應商提供了充滿希望的市場機會。

全球適體市場促進因素

藥物遞送技術的日益普及主要得益於標靶治療因其能夠最大限度減少非預期副作用而備受全球關注。這些標靶治療方案的日益普及推動了對適體的需求，適體是開發創新治療方法的關鍵材料。隨著對推進藥物遞送方法的投資不斷增加，適體市場憑藉其獨特的性質和在創建精準治療方案方面的有效性而經歷了顯著成長。因此，全球適體市場格局持續演變，其在現代藥物解決方案中的作用日益凸顯。

限制全球適體市場的因素

全球適體市場面臨許多挑戰，其中最主要的原因是適體固有的半衰期極短，通常只有幾分鐘到幾小時。這項限制使得適體的實際應用難以確定，並且在維持其穩定性和功能特性方面也面臨持續的挑戰。這些挑戰阻礙了適體潛力的充分發揮，進而影響了市場需求。儘管人們一直在努力克服這些挑戰，但適體有限的壽命仍然是限制其在各個領域廣泛應用的重要因素，這最終可能會影響市場的成長軌跡。

全球適體市場趨勢

全球適體市場的一大趨勢是透過創新化學修飾來增強其穩定性。供應商正致力於聚乙二醇化（PEGylation）和鎖核酸（LNA）修飾等技術，這些技術不僅能改善藥物動力學，還能最佳化標靶結合併最大限度地減少在生物系統中的分解。這項轉變正在拓寬適體的應用範圍，使其在治療和診斷應用上更加多樣化。因此，在適體工程技術的進步推動下，市場有望實現成長，這些進步有望克服現有治療方法的局限性，並拓展效用。

診斷試劑
- 生物標記檢測
- 病原體檢測
- 造影
- 伴隨診斷
治療藥物
- 腫瘤學
- 心血管疾病
- 感染疾病
- 眼科
- 發炎/自體免疫疾病
研究與開發
- 分子探針
- 目標檢驗
- 蛋白質相互作用研究
生物感測器
- 環境監測
- 食品安全
- 生物防禦應用
藥物輸送系統
- 精準投放
- 緩釋性

全球適體市場規模（依技術及複合年成長率分類）（2026-2033 年）

SELEX
- 常規SELEX
- 細胞篩選
- 毛細管電泳 SELEX
- 微流體SELEX
- 高通量SELEX
SELEX後最佳化技術
- 化學改性
- 斷開
- 二聚化
- 聚乙二醇化

全球適體市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

製藥和生物技術公司
學術和研究機構
臨床檢查室
受託研究機構（CRO）
診斷檢查室

全球適體市場規模（依地區分類）及複合年成長率（2026-2033）

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Aptamer Group（UK）
Aptadel Therapeutics（USA）
SomaLogic Operating Co., Inc.（USA）
Base Pair Biotechnologies（USA）
Vivonics, Inc.（USA）
Aptagen, LLC（USA）
Aptus Biotech（Spain）
TriLink BioTechnologies（USA）
AM Biotechnologies, LLC（USA）
Maravai LifeSciences（USA）

結論與建議

簡介目錄

Product Code: SQMIG35E2038

Global Aptamers Market size was valued at USD 0.1826 Billion in 2024 and is poised to grow from USD 0.22 Billion in 2025 to USD 0.8 Billion by 2033, growing at a CAGR of 17.8% during the forecast period (2026-2033).

The increasing prevalence of chronic diseases globally, coupled with the rising adoption of targeted therapies, is set to significantly boost the demand for aptamers. The need for early diagnostic solutions and heightened investment in innovative diagnostic technologies will further enhance market growth. Additionally, advancements in SELEX technology are poised to broaden the opportunities for aptamer market players. A surge in medical research and development investments, along with the growing utilization of genetic therapies and heightened awareness of aptamer benefits, will contribute to market expansion. However, challenges such as short half-lives, alternative solutions, limited acceptance, and stringent regulatory environments may impede demand. Notably, developed regions like the United States and Canada present promising market opportunities for aptamer providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aptamers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aptamers Market Segments Analysis

Global Aptamers Market is segmented by Type, Application, Technology, End-User and region. Based on Type, the market is segmented into DNA Aptamers, RNA Aptamers, XNA Aptamers, Peptide Aptamers and Aptamer-drug conjugates (ApDCs). Based on Application, the market is segmented into Diagnostics, Therapeutics, Research & Development, Biosensors and Drug Delivery Systems. Based on Technology, the market is segmented into SELEX and Post-SELEX Optimization Techniques. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical Laboratories,Contract Research Organizations(CROs) and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aptamers Market

The expanding focus on drug delivery technology has significantly fueled the emergence of targeted therapeutics, gaining traction globally due to their ability to minimize unforeseen side effects. This rising acceptance of targeted treatment solutions is propelling demand for aptamers, which are integral to the development of these innovative therapies. As more investments flow into the advancement of drug delivery methods, the market for aptamers is witnessing substantial growth, driven by their unique properties and effectiveness in creating precise therapeutic options. Consequently, the global landscape for aptamers is evolving, reinforcing their role in modern pharmaceutical solutions.

Restraints in the Global Aptamers Market

The Global Aptamers market faces significant challenges due to the inherently short half-life of aptamers, typically lasting only minutes to hours. This limitation complicates the identification of practical applications, as maintaining their stability and functional properties without degradation is a persistent difficulty. Such challenges hinder the ability to fully leverage the potential of aptamers, consequently impacting their market demand. As efforts continue to overcome these issues, the restricted lifespan of aptamers remains a critical factor that could impede their widespread adoption and utilization in various fields, ultimately influencing the growth trajectory of the market.

Market Trends of the Global Aptamers Market

The global aptamers market is witnessing a significant trend towards the enhancement of aptamer stability through innovative chemical modifications. Providers are increasingly focusing on techniques like PEGylation and locked nucleic acid (LNA) modifications, which not only improve pharmacokinetics but also optimize target binding and minimize degradation in biological systems. This shift is expanding the application scope of aptamers, making them more versatile for therapeutic and diagnostic uses. As a result, the market is poised for growth, driven by advancements in aptamer engineering that promise to address limitations in existing modalities and broaden their utility across various biomedical fields.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape

Global Aptamers Market Size by Type & CAGR (2026-2033)

Market Overview
DNA Aptamers
RNA Aptamers
XNA Aptamers
Peptide Aptamers
Aptamer-drug conjugates (ApDCs)

Global Aptamers Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostics
- Biomarker Detection
- Pathogen Detection
- Imaging Agents
- Companion Diagnostics
Therapeutics
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Ophthalmology
- Inflammatory & Autoimmune Diseases
Research & Development
- Molecular Probes
- Target Validation
- Protein Interaction Studies
Biosensors
- Environmental Monitoring
- Food Safety
- Biodefense Applications
Drug Delivery Systems
- Targeted Delivery
- Controlled Release Formulations

Global Aptamers Market Size by Technology & CAGR (2026-2033)

Market Overview
SELEX
- Conventional SELEX
- Cell-SELEX
- Capillary Electrophoresis SELEX
- Microfluidic SELEX
- High-throughput SELEX
Post-SELEX Optimization Techniques
- Chemical Modifications
- Truncation
- Dimerization
- PEGylation

Global Aptamers Market Size by End-User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Clinical Laboratories
Contract Research Organizations (CROs)
Diagnostic Laboratories

Global Aptamers Market Size & CAGR (2026-2033)

North America (Type, Application, Technology, End-User)
- US
- Canada
Europe (Type, Application, Technology, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, Technology, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, Technology, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, Technology, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Aptamer Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptadel Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SomaLogic Operating Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Base Pair Biotechnologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivonics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptagen, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptus Biotech (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriLink BioTechnologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AM Biotechnologies, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maravai LifeSciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments